If you have a tumour in the body or tail of the pancreas, and it sits against the splenic vein, the surgical conversation usually comes down to a trade. Keep the spleen and accept a higher risk of bleeding or infarction. Remove the spleen and accept the lifelong consequences of living without it. For most patients one of the two established techniques works well enough. For a minority, neither is a good option.
That minority is the subject of a case reported from Xi'an in November 2026.
1. The Two Standard Routes, and Where They Stop
Two operations have defined spleen-preserving pancreatic surgery for decades.
The Kimura technique, described in 1996, preserves the splenic artery and vein by carefully dissecting them away from the pancreas. It is the more physiological of the two: the spleen keeps its normal blood supply. But it depends on the vessels being separable. If a tumour has grown around them and the tissue is adherent, the dissection becomes dangerous — the vein can tear, and the bleeding is hard to control in that region.
The Warshaw technique, described in 1988, resects the splenic vessels along with the tumour and relies on the short gastric vessels to keep the spleen alive. It is simpler and can be used when the vessels are involved. The trade is that the spleen's blood supply is no longer normal. That carries a risk of splenic infarction, abscess, and regional portal hypertension, and some patients still end up losing the spleen afterwards.
Where a tumour encases the vein, Kimura is too risky and Warshaw may not preserve a functioning spleen. That is the gap.
2. What the Xi'an Team Did
The report, published by Xi'an Evening News on 9 November 2026, describes a 21-year-old patient from Qinghai with a tumour in the body and tail of the pancreas, attached to roughly 5cm of the splenic vein's outer wall. The article characterises the lesion as relatively "mild" but does not name the tumour type.
The hepatobiliary-pancreatic-splenic surgery team at Tangdu Hospital of the Air Force Medical University, led by director Yang Yanling, judged that neither standard technique was suitable: the tumour encased the vessels and the adhesion was severe.
The operation they performed proceeded in stages:
- Laparoscopic exploration and dissection of the splenic artery and vein.
- Transection of the pancreatic neck.
- Mobilisation of the pancreatic body and tail together with the spleen, and removal of the block through a small abdominal incision.
- Hypothermic perfusion of the organ outside the body while the tumour was resected and the involved section of splenic vein repaired.
- Return of the spleen to its original position.
- Microsurgical re-anastomosis of the splenic artery and vein.
The reported ischaemic time — the period without blood supply — was 45 minutes. The report states that flow was restored and the spleen returned from pale to pink with good perfusion.
The team named the operation the "Tangdu procedure" and states that a technology novelty search confirmed it as an internationally original technique.
3. What Was Reported, and What Was Not
This is where a case report and a clinical trial part company, and it matters if you are reading this as a patient.
Reported: the indication, the two standard techniques and why each was rejected, the operative sequence, the 45-minute ischaemic time, and immediate reperfusion of the spleen.
Not reported: the date of the operation, the patient's sex, the tumour's histological type, blood loss, operative duration, complications, length of stay, or any follow-up. The novelty search is attributed to an unnamed institution. We could not find a peer-reviewed publication describing the technique, nor an independent registry entry, at the time of writing.
None of that makes the report untrue. It means the claim should be read the way any single-case surgical report should be read: as a description of what one team did once, not as evidence that the operation is established, reproducible, or better than the alternatives. The "world's first" description is the hospital's, based on a novelty search; we are reporting it as their claim.
4. Why Keeping the Spleen Matters
It is worth being clear about what is at stake, because "spleen-preserving" can sound like a technical preference rather than a clinical one.
The spleen filters encapsulated bacteria — pneumococcus, meningococcus and Haemophilus influenzae in particular — from the blood. Patients who have had a splenectomy carry a lifelong risk of overwhelming post-splenectomy infection, which is uncommon but severe. That is why people without a spleen are vaccinated against those organisms and, in some cases, take preventive antibiotics. It is also why surgeons accept some additional technical difficulty to preserve a functioning spleen when the alternative is safe.
A preserved spleen only counts if it works. A spleen left in place with an inadequate blood supply can become an abscess or infarct, which is the specific concern that limits the Warshaw technique in some patients. That is the clinical logic behind an operation that restores the normal arterial and venous connections rather than relying on collateral flow.
5. What This Means If You Are the Patient
Three practical points.
Ask which technique is proposed, and why. For a body or tail tumour, the relevant question is whether the splenic vessels can be separated from the tumour. The answer comes from cross-sectional imaging reviewed by a hepatobiliary surgeon, not from the tumour's size alone.
Ask what happens if the spleen cannot be saved. Any spleen-preserving plan should include a contingency. If splenectomy becomes necessary, the vaccination and follow-up schedule should be planned before the operation, not after.
Treat a named technique as a question, not a promise. "We can do the Tangdu procedure" is not, by itself, a meaningful answer from a hospital you have not vetted. The useful questions are how many of these they have performed, what their outcomes are, and whether the approach has been published or presented somewhere you can read. For a technique described in a single case, the honest answer may be that the evidence is still being built.
6. Where This Was Done
Tangdu Hospital is in Xi'an, recorded in our directory as a Grade 3A hospital with an international department. Our directory lists it under thoracic surgery, neurosurgery, orthopaedics and general surgery; the report describes the work as coming from its hepatobiliary-pancreatic-splenic surgery centre. See the Tangdu Hospital page for what we hold on record.
Our directory does not currently record a pancreatic surgery designation, and we do not publish a ranking of pancreatic centres. What we can do is confirm, for a specific case, which hospitals will review the imaging and what they propose.
7. What It Costs
We do not publish a price for this procedure. Pancreatic resection is quoted per case after imaging and staging, because the operation depends on the tumour's relationship to the vessels and on what reconstruction is needed. If you want a figure, it has to come from a hospital that has seen your scans.
8. What This Does Not Promise
- One case is not a technique. A single reported operation does not establish safety, reproducibility or superiority. We found no peer-reviewed publication at the time of writing.
- The claims are the hospital's. The "world's first" and novelty-search statements come from the reporting institution.
- Outcome data were not reported. We cannot tell you how the patient fared beyond immediate reperfusion, because the source does not say.
- Availability is unknown. Whether this can be offered to another patient, at this hospital or elsewhere, is a clinical judgement we cannot make.
9. Frequently Asked Questions
What is the Tangdu procedure?
A spleen-preserving operation for tumours in the body or tail of the pancreas attached to the splenic vein. The pancreas and spleen are mobilised together, the spleen is perfused with cold fluid outside the body while the tumour is removed and the vein repaired, and the spleen is returned to its original position with the vessels reconnected under microsurgery.
Why keep the spleen at all?
The spleen filters encapsulated bacteria and supports immune defence against them. Removing it leaves a lifelong risk of severe infection, which is why patients without a spleen need vaccination and sometimes preventive antibiotics.
What are the Kimura and Warshaw techniques?
Both are established spleen-preserving operations. Kimura (1996) preserves the splenic vessels by dissecting them free. Warshaw (1988) removes the vessels and relies on short gastric vessels to keep the spleen alive. Kimura requires separable vessels; Warshaw can leave the spleen short of blood.
Is the Tangdu procedure available to international patients?
It is a single reported case, described in Chinese-language news and not yet, as far as we can find, in a peer-reviewed journal. Availability outside the reporting centre is unknown. Any patient with a body or tail tumour attached to the splenic vein should ask their surgical team whether a spleen-preserving option exists and what the evidence is.
How much does this operation cost in China?
We do not publish a price. Pancreatic surgery is quoted per case after imaging and staging, and we cannot give a figure without a hospital reviewing the records.
Ask About Pancreatic Surgery in China
If you or someone you are helping has a tumour in the body or tail of the pancreas, send the imaging report and pathology if available. We will tell you which hospitals will review the scans, what a surgical consultation would cover, and what to ask about spleen preservation. No obligation, 100% confidential, we reply within 24 hours.
- 📧 Email: contact@chinahospitalsguide.com
- 💬 WhatsApp: +86 157 6310 7083
- 📨 Telegram: @chinahospitalguide
- 💬 WeChat: chinahospitalguide
- 🌐 Start Free Case Review
Medical Disclaimer This article reports on a single surgical case described in a Chinese-language news report. It is general information and does not constitute medical advice, a treatment recommendation, or an invitation to seek care. It cannot replace an in-person consultation with a licensed physician. The "world's first" and novelty-search statements are the reporting hospital's. We found no peer-reviewed publication of the technique at the time of writing. Whether any operation is suitable for you must be assessed by a qualified surgical team after reviewing your imaging.
Source disclosure Case details are from Xi'an Evening News (西安新闻网), published 9 November 2026. The Kimura and Warshaw techniques are referenced from their original descriptions in the surgical literature. Hospital details are from our own directory record, which we state as our record rather than an independent assessment. We have no commercial relationship with Tangdu Hospital. China Hospitals Guide is an independent hospital-matching platform and does not accept commissions from hospitals.
